Stemsation International, Inc. (STSN)
Stemsation International, Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Plantation, FL, US. The stock last traded at $0.02, up 2.01% on the session, giving a market capitalisation of $1.5M. On trailing twelve-month figures it carries a trailing P/E of -23.86, a net margin of 0.0%. Its beta of 0.93 implies it has historically moved less than the broad market.
StemSation International, Inc., headquartered in Boca Raton, Florida, specializes in the development, manufacture, and distribution of natural wellness products. These offerings are specifically designed to bolster the human body's stem cell and endocannabinoid systems. Among its key products is StemRCM, a nutritional supplement created to enhance stem cells' natural capacity to mend, rejuvenate, and revitalize bodily tissues and organs. This is achieved by promoting healthy stem cell liberation, transport, and targeting within the system. The company markets its goods directly to consumers through a network of independent health advocates.
Stemsation International, Inc. is most often compared with the following Healthcare names: